Conjugated Factor VIII molecules

Details for Australian Patent Application No. 2009219232 (hide)

Owner Novo Nordisk A/S

Inventors Defrees, Shawn; Bolt, Gert; Vandahl, Brian Berg Stidsen; Thim, Lars; Stennicke,Henning Ralf; Steenstrup, Thomas Dock

Agent Shelston IP

Pub. Number AU-A-2009219232

PCT Pub. Number WO2009/108806

Priority 61/032,006 27.02.08 US

Filing date 26 February 2009

Wipo publication date 3 September 2009

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

19 August 2010 PCT application entered the National Phase

  PCT publication WO2009/108806 Priority application(s): WO2009/108806

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009219234-Method and apparatus for link control in a wireless communication system

2009219230-Steroid analogues for neuroprotection